Breakthrough T1D Brings Together Leading Experts at Islet Targeting Workshop
Breakthrough T1D is committed is to curing type 1 diabetes (T1D) through beta cell therapies, which is a complicated problem…
One Scientist’s Plan to Regenerate Beta Cells in Boston
Can we internally regenerate and protect beta cells, and therefore find cures for type 1 diabetes (T1D)? One scientist thinks…
Can Two Viral Drugs Halt Type 1 Diabetes?
Scientists in Norway are seeking participants for a clinical trial to see if a course of anti-viral treatment may stop…
Get To Know the Key People Behind Beta Cell Replacement Therapy in Boston
Join us for an inside look at the collaborations and skills that researchers in Boston are using to tackle the…
Join Us “Inside the Lab at Boston”
The work of type 1 diabetes (T1D) researchers is so compelling and full of hope. But it also is a…
Breakthrough T1D Funded Researcher Receives Prestigious Jacobus Prize
Mark Atkinson, Ph.D., a longtime Breakthrough T1D-funded researcher, is the recipient of 2019 Jacobus Prize for his research into the…
ViaCyte Does it Again: Insulin Production in People with T1D
ViaCyte, a beta cell replacement company long supported by Breakthrough T1D, has shown—for the first time ever—that its PEC-Direct therapy…
Trick or Treat: Have a scare-free and fun Halloween
To say that Halloween is ‘fun’ is an understatement! So many kids and adults look forward to this one evening…
EASD Brings World-Renowned Minds to Barcelona
For 55 years, leading researchers from around the world have gathered for the annual meeting of the European Association for…
Breakthrough T1D and Beyond Type 1 Launch Alliance
Today we announced an exciting new alliance with Beyond Type 1, aimed at getting more information, more resources, and more…
